Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

985 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A taxonomy of model structures for economic evaluation of health technologies.
Brennan A, Chick SE, Davies R. Brennan A, et al. Health Econ. 2006 Dec;15(12):1295-310. doi: 10.1002/hec.1148. Health Econ. 2006. PMID: 16941543
Modelling in health economic evaluation. What is its place? What is its value?
Brennan A, Akehurst R. Brennan A, et al. Pharmacoeconomics. 2000 May;17(5):445-59. doi: 10.2165/00019053-200017050-00004. Pharmacoeconomics. 2000. PMID: 10977387 Review.
Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule.
Stevenson M, Beard S, Finn A, Brennan A. Stevenson M, et al. Among authors: brennan a. Vaccine. 2002 Mar 15;20(13-14):1778-86. doi: 10.1016/s0264-410x(02)00025-7. Vaccine. 2002. PMID: 11906765
Evaluation of the impact of a technology appraisal process in England: the South and West Development and Evaluation Committee.
Dixon S, Coleman P, Nicholl J, Brennan A, Touch S. Dixon S, et al. Among authors: brennan a. J Health Serv Res Policy. 2003 Jan;8(1):18-24. doi: 10.1177/135581960300800106. J Health Serv Res Policy. 2003. PMID: 12683430
Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.
Brennan A, Bansback N, Reynolds A, Conway P. Brennan A, et al. Rheumatology (Oxford). 2004 Jan;43(1):62-72. doi: 10.1093/rheumatology/keg451. Epub 2003 Jul 30. Rheumatology (Oxford). 2004. PMID: 12890861
The role of modelling in prioritising and planning clinical trials.
Chilcott J, Brennan A, Booth A, Karnon J, Tappenden P. Chilcott J, et al. Among authors: brennan a. Health Technol Assess. 2003;7(23):iii, 1-125. doi: 10.3310/hta7230. Health Technol Assess. 2003. PMID: 14499052 Review.
Cost-effectiveness of sibutramine in the treatment of obesity.
Warren E, Brennan A, Akehurst R. Warren E, et al. Among authors: brennan a. Med Decis Making. 2004 Jan-Feb;24(1):9-19. doi: 10.1177/0272989X03261565. Med Decis Making. 2004. PMID: 15005950 Clinical Trial.
Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials".
Karnon J, Brennan A, Chilcott J. Karnon J, et al. Among authors: brennan a. Eur J Health Econ. 2003 Sep;4(3):239-40. doi: 10.1007/s10198-003-0191-4. Eur J Health Econ. 2003. PMID: 15609191 No abstract available.
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.
Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. Bansback NJ, et al. Among authors: brennan a. Drugs. 2005;65(4):473-96. doi: 10.2165/00003495-200565040-00004. Drugs. 2005. PMID: 15733011 Review.
Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK.
Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C, Akehurst R. Karnon J, et al. Among authors: brennan a. Curr Med Res Opin. 2005 Jan;21(1):101-12. doi: 10.1185/030079904x18036. Curr Med Res Opin. 2005. PMID: 15881481
985 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback